HighQC™ Human iPSC Derived Pericytes
HighQC™ Human iPSC Derived Pericytes,iPSC-derived pericytes for vascular biology, blood-brain barrier studies,tissue engineering and regenerative research.
胚胎干细胞、成体干细胞、肿瘤干细胞、间充质干细胞与 iPSCs(含 iPSC 衍生细胞),配套专用培养基与诱导方案。 共 669 个产品。
HighQC™ Human iPSC Derived Pericytes,iPSC-derived pericytes for vascular biology, blood-brain barrier studies,tissue engineering and regenerative research.
Support HighQC™ Human IPSC Derived Retinal Pigment Epithelium for ocular disease modeling, drug testing, and retinal pigment epithelium biology.
Advance research with HighQC™ Human IPSC From Activated Fibroblast From Primary Keratocytes-Keratoconus to model corneal disease and cell therapy.
ImmunoClone offers human iPS cell lines derived from Adipose Mesenchymal Stromal Cells.
HighQC™ Human IPSC From B-Lymphocyte-Apparently Healthy Individual is a human induced pluripotent stem cell line generated from B-lymphocytes isolated from the peripheral blood mononuclear cells (PBMCs) of a healthy donor. The cells serve as ideal controls for stem cell and developmental mechanism studies. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. These cells express the core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From B-Lymphocyte-Ceroid Lipofuscinosis to model CLN2-related neurodegeneration and support drug discovery for lysosomal disorders.
HighQC™ Human IPSC From B-Lymphocyte-Personal Genome Project is a human induced pluripotent stem cell line generated from B-lymphocytes isolated from the peripheral blood mononuclear cells (PBMCs) of a healthy donor participating in the Personal Genome Project. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. These cells possess the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. They express the core pluripotency marker SSEA-4 and retain B-lymphocyte-derived traits and reflect in vivo immune system physiology. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From B-Lymphocyte (Facioscapulohumeral Muscular Dystrophy 1), HighQC™ hiPSC FSHD1, hiPSC-FSHD1, HighQC™ Human Induced Pluripotent Stem Cells From B-Lymphocyte-Facioscapulohumeral Muscular Dystrophy Type 1
Use HighQC™ Human IPSC From Cord Blood Cells CD34+ for pluripotent stem cell research, differentiation, and disease modeling in hematopoietic systems.
Cell Type iPSC Primary Tissue Corneal epithelial cells Reprogramming Method Episomal Plasmid.
Leverage HighQC™ Human IPSC from Corneal Epithelial Cells-Diabetes, ideal for studying diabetes and reprogramming research using episomal plasmids.
HighQC™ Human IPSC from fibroblasts enables stem cell research, regenerative medicine, and modeling genetic diseases using pluripotent stem cells.
HighQC™ Human IPSC From Fibroblast (Niemann-Pick Disease Type A) supports sphingolipid metabolism and SMPD1-related lysosomal storage disorder modeling.
HighQC™ Human IPSC From Fibroblast-Alzheimer Disease is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Alzheimer's Disease (AD). The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They retain the fundamental capacity to differentiate into cell types representing all three germ layers—ectoderm, mesoderm, and endoderm — under appropriate directed differentiation protocols. These cells express the key pluripotency-associated marker SSEA-4. They maintain AD-related neuronal physiology and reflect neural tissue function. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human iPSC From Fibroblast-Amyotrophic Lateral Sclerosis provides high-quality patient-derived iPSCs to support neurodegenerative research.
HighQC™ Human IPSC From Fibroblast-Apparently Healthy Individual is a human induced pluripotent stem cell line derived from dermal fibroblasts of a healthy donor. These healthy individual induced pluripotent stem cells exhibit adherent growth and retain the fundamental capacity to differentiate into cell types representing all three germ layers (ectoderm, mesoderm, and endoderm) under defined conditions. They maintain normal cellular physiology and reflect in vivo physiological functions. These iPSCs (induced pluripotent stem cells) express the core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Charcot-Marie-Tooth Syndrome offers a patient-specific model for disease mechanisms, drug discovery and therapy testing.
HighQC™ Human IPSC From Fibroblast-Choroideremia is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Choroideremia, an X-linked recessive chorioretinal dystrophy caused by mutations in the CHM gene. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They maintain pluripotency and reflect CHM-related retinal traits. These cells retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
Employ HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation for rare genetic disease modeling, drug testing, and molecular studies.
HighQC™ Human iPSC From Fibroblast–Juvenile-Onset Diabetes provides an integration-free iPSC model for autoimmune diabetes research and drug. in vitro.
HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1 is a disease-specific induced pluripotent stem cell line generated from dermal fibroblasts of a donor diagnosed with Myotonic Dystrophy Type 1 (DM1). The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth and retain the fundamental capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives. These iPSCs express the core pluripotency marker SSEA-4. They retain DM1-related cellular features and reflect neuromuscular physiology in vivo. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Epidermolysis Bullosa: Dystrophic, Junctional, Or Simplex Types, ideal for disease modeling and therapeutic research.
HighQC™ Human IPSC From Fibroblast-Familial Alzheimer’s Disease models Alzheimer’s pathology and supports drug development using disease-relevant iPSCs.
HighQC™ Human IPSC From Fibroblast-Huntington Disease, HighQC™ hiPSC HD, hiPSC-HD, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Huntington Disease
共 669 个产品 | 第 10 / 28 页